Lord Abbett & CO. LLC Has $10.68 Million Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Lord Abbett & CO. LLC decreased its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 17.3% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 58,362 shares of the company’s stock after selling 12,206 shares during the quarter. Lord Abbett & CO. LLC owned 0.07% of Henry Schein worth $10,681,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Vanguard Group Inc. grew its stake in shares of Henry Schein by 3.0% during the 2nd quarter. Vanguard Group Inc. now owns 8,086,317 shares of the company’s stock valued at $1,479,959,000 after acquiring an additional 236,862 shares during the period. FMR LLC grew its stake in shares of Henry Schein by 0.4% during the 2nd quarter. FMR LLC now owns 6,921,367 shares of the company’s stock valued at $1,266,749,000 after acquiring an additional 24,935 shares during the period. BlackRock Inc. boosted its stake in Henry Schein by 1.8% in the 2nd quarter. BlackRock Inc. now owns 5,696,685 shares of the company’s stock worth $1,042,607,000 after purchasing an additional 101,406 shares during the period. State Street Corp boosted its stake in Henry Schein by 1.3% in the 1st quarter. State Street Corp now owns 3,675,674 shares of the company’s stock worth $624,760,000 after purchasing an additional 48,469 shares during the period. Finally, Janus Henderson Group PLC boosted its stake in Henry Schein by 394.1% in the 2nd quarter. Janus Henderson Group PLC now owns 1,465,303 shares of the company’s stock worth $268,173,000 after purchasing an additional 1,168,763 shares during the period. 48.16% of the stock is owned by institutional investors and hedge funds.

Henry Schein, Inc. (NASDAQ:HSIC) traded down $2.61 during trading on Friday, hitting $67.05. The stock had a trading volume of 5,071,400 shares, compared to its average volume of 1,106,182. The stock has a market capitalization of $10,933.44, a PE ratio of 19.54, a PEG ratio of 1.96 and a beta of 1.03. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.55 and a quick ratio of 0.85. Henry Schein, Inc. has a 1-year low of $67.02 and a 1-year high of $93.50.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Monday, November 6th. The company reported $0.87 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.90 by ($0.03). Henry Schein had a return on equity of 19.71% and a net margin of 4.52%. The company had revenue of $3.16 billion for the quarter, compared to analyst estimates of $3.05 billion. During the same period last year, the firm posted $0.84 EPS. The business’s quarterly revenue was up 10.3% on a year-over-year basis. equities analysts forecast that Henry Schein, Inc. will post 3.6 EPS for the current fiscal year.

Henry Schein announced that its Board of Directors has authorized a stock buyback program on Monday, September 18th that authorizes the company to buyback $400.00 million in outstanding shares. This buyback authorization authorizes the company to buy up to 6.3% of its stock through open market purchases. Stock buyback programs are often an indication that the company’s board of directors believes its shares are undervalued.

In related news, SVP Paul Rose sold 2,126 shares of the business’s stock in a transaction on Wednesday, September 6th. The stock was sold at an average price of $172.51, for a total value of $366,756.26. Following the sale, the senior vice president now owns 17,841 shares in the company, valued at approximately $3,077,750.91. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.19% of the stock is owned by insiders.

Several research firms have weighed in on HSIC. Royal Bank of Canada dropped their price target on Henry Schein from $91.00 to $82.00 and set a “sector perform” rating for the company in a research note on Tuesday. Jefferies Group LLC reiterated a “hold” rating and set a $89.00 target price on shares of Henry Schein in a research report on Friday, October 20th. Credit Suisse Group restated a “hold” rating and set a $87.50 price target on shares of Henry Schein in a report on Tuesday, August 29th. Leerink Swann restated a “market perform” rating and set a $77.00 price target (down previously from $87.50) on shares of Henry Schein in a report on Tuesday. Finally, Morgan Stanley started coverage on Henry Schein in a report on Thursday, September 21st. They set an “equal weight” rating and a $88.00 price target on the stock. One research analyst has rated the stock with a sell rating, nine have given a hold rating and seven have issued a buy rating to the company’s stock. Henry Schein currently has a consensus rating of “Hold” and an average target price of $89.88.

TRADEMARK VIOLATION WARNING: “Lord Abbett & CO. LLC Has $10.68 Million Stake in Henry Schein, Inc. (NASDAQ:HSIC)” was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this report on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The legal version of this report can be accessed at https://www.dispatchtribunal.com/2017/11/11/lord-abbett-co-llc-cuts-stake-in-henry-schein-inc-hsic.html.

Henry Schein Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply